HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.

Abstract
Triheptanoin is anticonvulsant in several seizure models. Here, we investigated changes in glucose metabolism by triheptanoin interictally in the chronic stage of the pilocarpine mouse epilepsy model. After injection of [U-13C6]-glucose (i.p.), enrichments of 13C in intermediates of glycolysis and the tricarboxylic acid (TCA) cycle were quantified in hippocampal extracts and maximal activities of enzymes in each pathway were measured. The enrichment of 13C glucose in plasma was similar across all groups. Despite this, we observed reductions in incorporation of 13C in several glycolytic intermediates compared to control mice suggesting glucose utilization may be impaired and/or glycogenolysis increased in the untreated interictal hippocampus. Triheptanoin prevented the interictal reductions of 13C incorporation in most glycolytic intermediates, suggesting it increased glucose utilization or - as an additional astrocytic fuel - it decreased glycogen breakdown. In the TCA cycle metabolites, the incorporation of 13C was reduced in the interictal state. Triheptanoin restored the correlation between 13C enrichments of pyruvate relative to most of the TCA cycle intermediates in "epileptic" mice. Triheptanoin also prevented the reductions of hippocampal pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase activities. Decreased glycogen breakdown and increased glucose utilization and metabolism via the TCA cycle in epileptogenic brain areas may contribute to triheptanoin's anticonvulsant effects.
AuthorsTanya McDonald, Mark P Hodson, Ilya Bederman, Michelle Puchowicz, Karin Borges
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (J Cereb Blood Flow Metab) Vol. 40 Issue 3 Pg. 678-691 (03 2020) ISSN: 1559-7016 [Electronic] United States
PMID30890077 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Triglycerides
  • triheptanoin
  • Ketoglutarate Dehydrogenase Complex
  • Pyruvate Decarboxylase
  • Glucose
Topics
  • Animals
  • Chronic Disease
  • Citric Acid Cycle (drug effects)
  • Disease Models, Animal
  • Epilepsy (metabolism, pathology)
  • Glucose (analogs & derivatives, pharmacokinetics, pharmacology)
  • Glycolysis (drug effects)
  • Hippocampus (metabolism, pathology)
  • Ketoglutarate Dehydrogenase Complex (metabolism)
  • Male
  • Mice
  • Pyruvate Decarboxylase (metabolism)
  • Triglycerides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: